EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Total Debt History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹48 Cr | ₹58 Cr | ₹52 Cr | ₹39 Cr | ₹23 Cr |
What is the latest Total Debt ratio of EVEREST ORGANICS ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹48 Cr |
| Mar2024 | ₹58 Cr |
| Mar2023 | ₹52 Cr |
| Mar2022 | ₹39 Cr |
| Mar2021 | ₹23 Cr |
How is Total Debt of EVEREST ORGANICS Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹48 Cr | -17.16 | |
| Mar2024 | ₹58 Cr | 11.84 | |
| Mar2023 | ₹52 Cr | 33.25 | |
| Mar2022 | ₹39 Cr | 69.35 | |
| Mar2021 | ₹23 Cr | - | |
Compare Total Debt of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹403.5 Cr | 3.4% | -20.4% | 54.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,559.0 Cr | 7.1% | -1.5% | -6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,827.0 Cr | 2.8% | -2.8% | 6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,942.0 Cr | 3.1% | 4.2% | 18.8% | Stock Analytics | |
| CIPLA | ₹106,825.0 Cr | 0.2% | -12.5% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,077.0 Cr | 2.2% | -1.6% | 0% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | 3.4% |
-20.4% |
54.8% |
| SENSEX | 1.7% |
-1.7% |
10.3% |
You may also like the below Video Courses